Company facts
- Headquarters
- Rockville, Maryland
- Most recent report
- 8-K, filed Oct 14, 2026
- Incorporated
- Delaware
- Filings on record
- 335 filings
- On EDGAR
- CIK 1287098
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 22
News 8 of 53
- 8-K Quarterly results Oct 14, 2026
- 8-K Quarterly results Aug 12, 2026
- 8-K Shareholder vote results Jun 17, 2026
- 8-K Current report on a material event Jun 16, 2026
- 8-K Quarterly results May 12, 2026
- 8-K Leadership change Mar 27, 2026
- 8-K Quarterly results Mar 24, 2026
- 8-K Current report on a material event Mar 20, 2026
Prospectuses and Registrations 7
- S-8 Registration statement for an employee plan Apr 15, 2026
- S-8 Registration statement for an employee plan Aug 26, 2025
- S-8 Registration statement for an employee plan Jul 14, 2022
- S-8 Registration statement for an employee plan Aug 5, 2021
- 424B4 Final prospectus for an offering Jul 30, 2021
- S-1/A Registration statement for an offering, amended Jul 26, 2021
- S-1 Registration statement for an offering Jul 9, 2021
Proxies 8 of 9
- DEFA14A Extra proxy material Apr 29, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2026
- DEFA14A Extra proxy material May 29, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2025
- PRE 14A Preliminary proxy statement Apr 15, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2023
- DEF 14A Proxy statement for a shareholder vote May 26, 2022
Ownership 8 of 218
- SCHEDULE 13D Large holder reported an active stake Oct 15, 2026
- SCHEDULE 13D Large holder reported an active stake Aug 4, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 29, 2026
- 4 Insider reported a trade Jun 22, 2026
- 4 Insider reported a trade Jun 22, 2026
- 4 Insider reported a trade Jun 22, 2026
- 4 Insider reported a trade Jun 22, 2026
- 4 Insider reported a trade Jun 22, 2026
Other 8 of 26
- ARS Annual report sent to shareholders Apr 29, 2026
- ARS Annual report sent to shareholders Apr 28, 2025
- ARS Annual report sent to shareholders May 1, 2024
- ARS Annual report sent to shareholders Apr 28, 2023
- EFFECT Notice that a registration became effective Jul 29, 2021
- S-1MEF Jul 29, 2021
- CERT Exchange certified a listing Jul 29, 2021
- CORRESP Reply to SEC staff Jul 27, 2021
Everything here comes from Maxcyte, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.